Experienced in Osteosclerosis Autosomal Dominant

Dr. Chrystal U. Louis

Pediatric Hematology Oncology
6701 Fannin St, 
Houston, TX 
Experienced in Osteosclerosis Autosomal Dominant
6701 Fannin St, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Chrystal Louis is a Pediatric Hematologist Oncology provider in Houston, Texas. Dr. Louis is rated as an Experienced provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Anemia, and Leukemia.

Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Osteosclerosis Autosomal Dominant.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

6701 Fannin St, Houston, TX 77030

Additional Areas of Focus

Dr. Louis has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase I/II Study Using Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma (ATOMIC)
A Phase I/II Study Using Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma (ATOMIC)
Enrollment Status: Active_not_recruiting
Publish Date: August 01, 2025
Intervention Type: Drug, Biological
Study Drugs: Neuroblastoma Vaccine (Unmodified SKNLP, with Gene-Modified SJNB-JF-IL2 and SJNB-JF-LTN Neuroblastoma Cells, Cytoxan
Study Phase: Phase 1/Phase 2
A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells After High-Dose Chemotherapy And Autologous Stem Cell Rescue In Patients With High Risk Neuroblastoma
A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells After High-Dose Chemotherapy And Autologous Stem Cell Rescue In Patients With High Risk Neuroblastoma
Enrollment Status: Completed
Publish Date: July 04, 2025
Intervention Type: Biological
Study Drug: SNJB-JF-IL2 and SJNB-JF-Lptn + SKNLP
Study Phase: Phase 1/Phase 2
Administration of Peripheral Blood T-Cells and EBV Specific CTLs Transduced to Express GD-2 Specific Chimeric T Cell Receptors to Patients with Neuroblastoma
Administration of Peripheral Blood T-Cells and EBV Specific CTLs Transduced to Express GD-2 Specific Chimeric T Cell Receptors to Patients with Neuroblastoma
Enrollment Status: Active_not_recruiting
Publish Date: January 10, 2025
Intervention Type: Biological
Study Drug: EBV Specific CTLs
Study Phase: Phase 1
View 2 Less Clinical Trials

35 Total Publications

International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.
Journal: Cytotherapy
Published: April 25, 2024
Similar Doctors
Experienced in Osteosclerosis Autosomal Dominant
Dr. Andras A. Heczey
Pediatric Hematology Oncology
Experienced in Osteosclerosis Autosomal Dominant
Dr. Andras A. Heczey
Pediatric Hematology Oncology
6621 Fannin St, 
Houston, TX 
 (0.1 miles away)
832-824-1000
Languages Spoken:
English
See accepted insurances

Andras Heczey is a Pediatric Hematologist Oncology provider in Houston, Texas. Dr. Heczey is rated as a Distinguished provider by MediFind in the treatment of Osteosclerosis Autosomal Dominant. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, and Infantile Neutropenia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Louis's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile